| |
|
|
|
Hemispherx Biopharma- Inc.  
|
|
0.2753 -0.008 (-0.03%) |
08-17 16:00 |
|
Open: |
0.283 |
Pre close: |
0.283 |
Target:
|
0.35 
|
|
High: |
0.2831 |
Low: |
0.2601 |
Resistance:
|
0.30
0.32
|
|
Volume: |
334,278 |
Market Cap: |
13M |
Support:
|
0.26
0.22
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.29
|
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
0.30 |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
0.32 |
Stochastic Oscillator |
%K(14,3):
|
10.15 |
|
MA(250): |
0.36 |
%D(3): |
20.05 |
|
Average Volume(K) |
3-Month: |
37235
|
52-Week |
High:
|
0.65 |
|
10-Days: |
15400 |
Low: |
0.26 |
|
RSI |
RSI(14):
|
33.46 |
Change(%): |
-25.6 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-70.4 |
Shares Out. (M) |
47.21 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-49.2 |
Shares Float (M) |
43.70 |
|
EPS Est. Next Year |
-0.030 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.90 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-33.3 |
% Held by Institutions |
6.30 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
545 |
|
Book Value (p.s.) |
1.370 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.20 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-7.49 |
P/S |
1299691264.00 |
|
Operating Margin |
-2625.43 |
Levered Free Cash Flow
(M) |
-4.94 |
P/CF |
-1.74 |
|
|
|
|
|
|
